Economic and Financial Impacts of Cancer
Moving in JNCI: Journal of the National Cancer Institute, The Lancet Oncology, Journal of Clinical Oncology, JAMA Oncology, The Lancet Global Health, Journal of Thoracic Oncology, medRxiv and Nature Reviews Cancer.
- Moved, week to 17 Nov 2026
- 0
- Papers in 60 days
- 31
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Economic and Financial Impacts of Cancer
Newest first · last 60 days
AI summary · may contain errors
Interventions in low-income and middle-income countries are associated with reduced paediatric cancer treatment abandonment, with a pooled risk ratio of 0·33 (95% CI 0·24–0·45).
- Open access
- 1 cites
AI summary · may contain errors
Five-year net survival for eleven common cancers in the Commonwealth is estimated at 30·7% in 2020, ranging from 4·1% in low-income countries to 59·0% in high-income countries.
- 6 cites
AI summary · may contain errors
Medicines newly added to the WHO Model List of Essential Medicines (2002–2023) show lower uptake in lower-GDP countries, and complex genomic diagnostics are linked to 65% lower standard-unit uptake overall.
- Open access
AI summary · may contain errors
Each 10-point increase in total ESAS symptom burden is linked to a 9.4% decrease in 30-day cancer-directed treatment costs in Ontario adults after diagnosis.
- 1 cites
AI summary · may contain errors
Net annualized cancer-attributable medical service costs were highest in the end-of-life phase at $121,746, exceeding initial ($45,063) and continuing ($7,141) phases in SEER-Medicare older adults.
- 2 cites
AI summary · may contain errors
Dose optimization and pragmatic de-escalation are presented as strategies for financially constrained health systems to make care more efficient without compromising appropriate use.
AI summary · may contain errors
An IRAOOPcap of $2,000 annual out-of-pocket costs for Medicare Part D beneficiaries with newly diagnosed multiple myeloma is projected to yield 0.17–0.18 life-years gained in ages 66–75 under realistic-to-best IMiD adherence scenarios.
AI summary · may contain errors
In the LIFT pragmatic hybrid II trial across eight oncology practice sites, FACIT-COST scores improved by an average 8.1 points after financial navigation, including both rural and nonrural settings.
- Open access
- 1 cites
AI summary · may contain errors
Reimbursement for cancer treatment modalities in the US shows a current contrast that this Viewpoint seeks to clarify.
AI summary · may contain errors
Biosimilar entry for bevacizumab, rituximab, and trastuzumab in US oncology is linked to a 3.8% annual ASP decline and falling reference market share.
- Open access
AI summary · may contain errors
In 2022 claims for 12,134 Medicare and commercially insured patients with blood-cancer SOAM prescriptions, only 9.6% (Medicare) and 4.0% (commercial) were approved and filled initially.
- Open access
- 1 cites
AI summary · may contain errors
Among 3,999 hospitals, 340B participants reported lower charity care (2.16% vs 2.82% of operating expenses) and lower charity care for uninsured patients (1.60% vs 2.26%), but higher Medicaid admission days (19.69% vs 17.76%).
- Open access
Browse JClub
Journals this month
- bioRxiv6386
- medRxiv1756
- PNAS556
- JAMA352
- Sci Adv330
- Cell Rep314
- Environ Res213
- BMJ209
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- NEJM148
- New Phytol145
- Curr Biol130
- Nature127
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
